Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

BENZOCAINE AND MENTHOL

Active
SPE2DP-26-T-4388Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

2900 DOOLITTLE DR BLDG 6000, ELLSWORTH AFB, SD, 57706-4821, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Vanesa M Carbo Acevedo
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
BENZOCAINE AND MENTHOL LOZENGE
BENZOCAINE 15 MG-MENTHOL 10 MG LOZENGES 15S
CHLORASEPTIC MAX 15-10 MG LOZ 15S
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
UOI PK
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS (IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
AMERISOURCEBERGEN DRUG CORP 1XUY5 P/N NDC78112-0017-46
SPE2DP-26-T-4388
SECTION B
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017402563 0001 PG 6.000
NSN/MATERIAL:6505017061600
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:U
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4388
SECTION B
PR: 7017402563 PRLI: 0001 CONT’D
PARCEL POST ADDRESS:
FY2922
FY2922 28TH MDG SGSM
CP 6053853468
2900 DOOLITTLE DR BLDG 6000
ELLSWORTH AFB SD 57706-4821
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
FY2922
FY2922 28TH MDG SGSM
CP 6053853468
2900 DOOLITTLE DR BLDG 6000
ELLSWORTH AFB SD 57706-4821
US
M/F: (TCN) FM452861830032
RDD:
PROJ: TP 1
SUPP ADD: FY2922 SIG: J
FOR GOVERNMENT USE ONLY: (IPD) 03
DIC: A0A DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/09/2026
SPE2DP-26-T-4388 NSN/Part Number: 6505-01-706-1600 Quantity: 6 PG Purchase Request: 7017402563QTY: 6 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
Supply of Electrochemiluminescence (ECL) Performance Qualification KitThe contract solicits the supply and delivery of a reagent-based medical kit designed for performance qualification of Electrochemiluminescence (ECL) instrumentation, specifically compatible with the MSD PR2 Model 1800. The kit includes ten plates and all necessary reagents to ensure accurate and reliable validation of the instrument’s operational parameters. This subcontract is part of the Department of Defense’s Medical Supply Chain initiative under the agency name MEDICAL SUPPLY CHAIN MD SURG FSF, with performance required at the APO location identified by zip code 96328-5225. The solicitation was posted on July 29, 2026, and responses are due by August 4, 2026, with a NAICS code of 325411 indicating the industry classification for pharmaceutical and medicine manufacturing. The purpose is to maintain the integrity and accuracy of diagnostic testing equipment used in military medical operations.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
NIRMATRELVIR AND RI
Solicitation # SPE2DP-26-T-4361
The contract is for the procurement of 50 boxes of Nirmatrelvir and Ritonavir tablets, marketed as Paxlovid, with each box containing 10 blister cards, each card housing three tablets—two 150 mg Nirmatrelvir and one 100 mg Ritonavir—providing a five-day supply of two daily doses per box. The item is designated by NSN 6505017227590 and manufacturer part number NDC00069-5321-30, supplied by Pfizer Inc. The contract requires delivery of all units within 20 calendar days of order receipt to the Navy Expeditionary Central Facility in Williamsburg, Virginia, under FOB Destination terms, meaning the contractor bears all transportation costs and risks until receipt at the destination. The product is regulated by the FDA and subject to strict shelf-life controls requiring a minimum 36-month non-extendable shelf life under RS020. Packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection against damage through sealed unit packaging and commercial-grade shipping containers, with palletization conforming to DLA packaging requirements. Each unit must be labeled with NSN, lot number, expiration date, and contain a 2D Data Matrix barcode for automated logistics tracking. The contract is a firm-fixed-price procurement with no tolerance for quantity variance, and payment must be submitted electronically via WAWF. All offerings must include the manufacturer’s source and part number, and the contractor must comply with federal regulations regarding hazardous materials, cybersecurity safeguards, cybersecurity incident reporting, prohibition of covered telecommunications equipment, and prohibitions on hexavalent chromium and toxic material handling. Offerors must hold a valid UEI and CAGE code and affirm compliance with Equal Opportunity, Combating Trafficking in Persons, Employment Eligibility Verification, and Sustainable Products requirements. The solicitation closed on August 4, 2026, with award expected shortly thereafter under the DLA Automated Simplified Acquisition framework.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
MORPHINE SULFATE IN
Solicitation # SPE2DP-26-T-4360
Morphine Sulfate Injection, 10 mg/mL in 1x10 Nexject units, classified as DEA C-II, is being procured under solicitation SPE2DP-26-T-4360 with a requirement for delivery within 20 days of contract award, no later than July 30, 2026, to a destination address in APO AE 09094-3219. The item is packaged as a unit of issue of 10 pieces per package and must be stored at controlled room temperature. The product has a strict, non-extendable 18-month shelf life under RS013 as a Type I Code K item, and all packaging must comply with MIL-STD-2073-1E and DLA Packaging Requirements (RP001), with marking governed exclusively by Medical Marking Standard No. 1, which supersedes MIL-STD-129. The manufacturer is Pfizer Inc, with NDC 00409-1893-23, and the materiel is regulated by the FDA, requiring a referral to the product specialist for confirmation before award. Inspection and acceptance occur at the destination, with zero variance allowed in quantity, and payment is processed exclusively through WAWF. The contract incorporates a comprehensive set of federal and defense acquisition regulations including clauses on hazardous materials handling, cybersecurity safeguards, trafficking in persons, employment eligibility, sustainable products, and controls for covered defense information. The contractor must remove all government identification from non-accepted supplies and comply with all requirements listed in the DLA Master List of Technical and Quality Requirements. Security and compliance mandates include adherence to NIST SP 800-171, safeguarding covered defense information, and reporting cyber incidents, while also ensuring full compliance with hazardous material labeling under OSHA standards and submission of Safety Data Sheets prior to award. Small business socioeconomic certifications and UEI or CAGE code disclosures are required, particularly if participating in joint ventures, and representations regarding compensation of former DoD officials and the use of prohibited telecommunications equipment must be explicitly addressed. All submissions must be made electronically via DIBBS by August 4, 2026, under a fixed-price contract type to be determined, with no pricing details provided in the solicitation, indicating offerors must submit competitive unit prices.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days
View Details
NAICS: 325411
New
DIBBS
Therapeutic Dietary Supplement Manufacturing & FormulationThe contract seeks the manufacture of an unflavored, lactose-free therapeutic dietary supplement in powder form, with each packet containing 80 grams of product designed to be reconstituted into 8 to 10 ounces of liquid. The formulation must strictly comply with both FDA regulations and U.S. military nutritional standards, ensuring suitability for therapeutic use in controlled environments. Production must maintain consistent quality, stability, and safety profiles to meet the rigorous requirements of institutional and clinical applications under military oversight. The opportunity is issued as a subcontract under the NAICS code 325411 for Pharmaceutical and Biological Product Manufacturing, with a response deadline of August 5, 2026. Performance is required at Perry Point, Maryland, 21902, under the purview of the Department of Defense’s Medical Supply Chain PHFS. The solicitation is open to qualified manufacturers capable of scaling production reliably while adhering to all regulatory and nutritional specifications, with no set-aside provisions indicated. Bidders must ensure full alignment with the technical and compliance conditions outlined in the contract’s governing framework.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
PHENYLEPHRINE HYDRO
Solicitation # SPE2DP-26-T-4342
The contract specifies the procurement of Phenylephrine Hydrochloride Ophthalmic Solution USP 2.5% in 10 mL sterile, aqueous, topical bottles manufactured by Bausch & Lomb Americas Inc. with NDC 82260-0102-10, to be delivered in a quantity of six bottles under solicitation SPE2DP-26-T-4342. The product must be stored at 2°C to 25°C (36°F to 77°F) and packaged in sealed unit containers that protect against damage, with all outer shipping containers meeting commercial standards for safe transport by common carrier at the lowest cost to the designated destination in Williamsburg, VA. Packaging and marking must comply with Medical Marking Standard No. 1, replacing all references to MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The item has a non-extendable shelf life of 24 months as a TYPE I (CODE M) product and must be labeled accordingly. The solution is contained in opaque white LDPE bottles with LLDPE dropper tips and red caps, and the entire shipment must be delivered FOB destination within five days of the order. Shipment must be sent by the fastest traceable means; parcel post is prohibited. Delivery is required by April 15, 2026, with inspection and acceptance occurring at the destination point. The National Stock Number is 6505017090360 and the purchase request number is 7016297029. The item is regulated by the FDA, requiring a referral to the product specialist through EBS with full bidder and manufacturer details. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, with the revision in effect on the solicitation issue date controlling. Contract-specific identifiers, including CLIN, pricing, and unit of issue, are structured under the DoD authorized unit of issue system, and all documentation must reflect current DLA standards for marking, packaging, and logistics. The point of contact for inquiries is James Mariani of the Department of Defense Medical Supply Chain.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
VERAPAMIL HYDROCHLORID
Solicitation # SPE2DP-26-T-4330
Verapamil hydrochloride injection is a 5 mg per 2 mL solution packaged in 2 mL single-dose glass fliptop vials, supplied in packs of 25, and is preservative-free for intravenous use only. The product must be protected from light and stored at controlled room temperature between 20 to 25°C (68 to 77°F), conforming to USP standards. It has a non-extendable shelf life of 24 months from the date of manufacture, and no more than four months may have elapsed between manufacture and delivery to the government. The item is identified by NSN 6505-01-738-0226 and is subject to stringent technical and quality requirements as defined in the DLA Master List, with packaging and handling governed by DLA procurement standards. Government identification must be removed from non-accepted supplies, and covered defense information provisions apply. The solicitation, issued under SPE2DP-26-T-4330 on July 28, 2026, with a response deadline of August 3, 2026, is for a federal procurement through the Department of Defense’s Medical Supply Chain PHARM FSA, with delivery required within five days of award, and the point of contact is Daniel Porter at daniel.porter@dla.mil.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
DIETARY SUPPLEMENT, THE
Solicitation # SPE2DP-26-Q-0125
The contract specifies the procurement of an unflavored therapeutic dietary supplement in powder form, with each package containing six individual packets, each yielding 8 to 10 ounces of liquid when reconstituted. The product is lactose-free and must have a shelf life of 18 months, with no more than three months elapsed between manufacture and delivery to the government. Each package must be sealed in a unit container that protects the contents from damage and packed in commercial shipping containers suitable for safe transport at the lowest cost to the delivery point. All packaging and labeling must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and must adhere to DLA’s Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. Palatalization must follow DLA Packaging Requirements for Procurement. The unit of issue is the package, with four packages required, delivered in two separate shipments to two distinct government addresses—one in Perry Point, Maryland, and another in San Antonio, Texas—by traceable freight means only, prohibiting parcel post. Delivery is required within 35 days after order date, with inspection and acceptance occurring at the destination. Pricing is firm fixed, with no variance allowed in quantity. The supplier must comply with federal clauses related to veteran employment reports, sustainable products, and wide area workflow payment. The item’s NSN is 8940-01-317-9838, and the solicitation number is SPE2DP-26-Q-0125.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 5 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATE
Solicitation # SPE2DP-26-T-4339
Sumatriptan Succinate Tablets, 100 mg in bottles of nine tablets, are procured for the acute treatment of migraine with or without aura in adults, with storage requirements between 20 to 25°C (68 to 77°F) and protection from light. The item is regulated by the FDA and must comply with strict shelf-life standards, requiring a non-extendable 24-month shelf life per RS016 and RS001 for Type I (Code M) items. Packaging and marking must adhere to MIL-STD-2073-1E, MIL-STD-129, and the latest Medical Marking Standard No. 1, while palletization follows DLA Packaging Requirements for Procurement. The contract specifies three line items totaling seven bottles, with delivery due within five days of order, FOB destination, and zero tolerance for quantity variance. Deliveries are directed to multiple U.S. military locations including APO AE 09094-3219 and JBER AK 99506, with shipping details and contact information provided for each. The solicitation number SPE2DP-26-T-4339 is issued by the Department of Defense, with procurement governed by the DLA Master List of Technical and Quality Requirements, and requires pre-award confirmation via EBS referral including manufacturer and NDC details. The required delivery dates span late July to late August 2026, with an established response deadline of August 3, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
DIBBS
BENZOCAINE AND MENTHOL
Solicitation # SPE2DP-26-T-4334
The contract is for the procurement of Benzocaine and Menthol under National Stock Number 6505-01-708-1449 with a requested quantity of three units. The solicitation, identified by number SPE2DP-26-T-4334, was posted on July 28, 2026, and responses are due by August 3, 2026. It is issued by the Defense Logistics Agency under the Department of Defense and falls under NAICS code 424210, indicating distribution in pharmaceutical and botanical products. The solicitation is targeted at federal entities with no specific set-aside classification. The point of contact for the procurement is James Foggie, reachable via email at james.foggie@dla.mil or phone at 4457373211. The place of performance and office address details are unspecified, though the country of origin is listed as the United States. Further information and submission details can be accessed through the official DIBBS platform using the provided UI link.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

3 days ago

DEADLINE

in 3 days
View Details
NAICS: 325411
New
Federal
Surge-Capable Domestic BiomanufacturingThe contract seeks to establish large-scale domestic manufacturing of dermal substitutes in the United States with built-in surge capacity to support mass casualty and emergency response scenarios. The effort is focused on creating a resilient, onshore production capability capable of rapidly scaling output during public health emergencies, ensuring timely availability of critical wound care products when demand spikes. This initiative is aligned with national preparedness goals and underscores a strategic push to reduce reliance on overseas supply chains for life-saving medical materials. The award is structured as a subcontract under the Administration for Strategic Preparedness and Response within the Department of Health and Human Services, with a North American Industry Classification System code of 325411 for pharmaceutical and medicine manufacturing. The solicitation was posted on July 28, 2026, and responses are due by August 28, 2026. Although the place of performance is listed with a zip code of 77416, no specific city or state is provided, and no point of contact details are included. The contract does not specify a set-aside status, indicating it is open to all qualified entities regardless of size or ownership. The focus remains on achieving domestic production capacity that can maintain steady output and immediately ramp up during crises.
Aspr Administration For Strategic Preparedness And Response

POSTED

3 days ago

DEADLINE

in 28 days
View Details
NAICS: 325411
New
Federal
Active Pharmaceutical Ingredient (API) SupplyNac Pharmaceuticals is seeking a subcontractor to supply Pioglitazone Active Pharmaceutical Ingredient (API) that meets USP-NF standards and complies with the Trade Agreements Act for use in the manufacturing of finished dosage forms. The opportunity is posted under NAICS code 325411, indicating classification within pharmaceutical preparation manufacturing, and the response deadline is August 13, 2026, at 7:30 PM Eastern Time. The API must adhere strictly to pharmacopeial specifications to ensure quality, safety, and compatibility with regulatory requirements for final product approval. The place of performance and point of contact details are not specified, suggesting the supplier’s location and logistics are flexible as long as deliverables meet contractual obligations. This procurement is part of a broader initiative by the Department of Veterans Affairs through its contractor Nac Pharmaceuticals, to secure a reliable supply chain for critical drug components in support of federal healthcare programs.
Nac Pharmaceuticals (36E797)

POSTED

3 days ago

DEADLINE

in 13 days
View Details
NAICS: 325411
New
International
W7702-266459 SYNTHESIS OF MOLECULES OF INTEREST
Solicitation # WS5762399690
All bids for the synthesis of molecules of interest must be submitted by August 4, 2026 at 2:00 PM EDT, with any submissions after this time deemed non-responsive, overriding any earlier deadlines listed on Ariba Discovery or CanadaBuys. The contract, titled W7702-266459, is issued by Defence Research and Development Canada – Suffield Research Centre for the production of organic, organophosphorus, pesticide-related, and pharmaceutical molecules, with a base term of one year and four optional one-year extensions available at the Crown’s discretion. The Government of Canada retains full ownership of all foreground intellectual property generated under this contract. The solicitation, numbered WS5762399690, was posted on July 28, 2026, and is managed by the Department of Public Works and Government Services with primary contact Matthew Havrilenko at matthew.havrilenko@tpsgc-pwgsc.gc.ca. Performance will occur in Alberta, and the NAICS code 325411 applies.
Department of Public Works and Government Services

POSTED

3 days ago

DEADLINE

in 4 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
CARPROFEN TABLETS
Solicitation # SPE2DP-26-T-4392
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
PENTOBARBITAL SODIU
Solicitation # SPE2DP-26-T-4387
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
LIDOCAINE HYDROCHLORID
Solicitation # SPE2DP-26-T-4390
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR INJECTION, ST
Solicitation # SPE2DP-26-T-4380
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
ERYTHROMYCIN OPHTHALMI
Solicitation # SPE2DP-26-T-4394
ERYTHROMYCIN OPHTHALMIC OINTMENT USP is a sterile, topical ointment containing 5 mg of erythromycin per gram in a base of mineral oil and white petrolatum, intended for ophthalmic use only. Each unit is packaged as a single-dose tube containing 3.5 grams of ointment, with 24 tubes per package, defined as the unit of issue. The product must have a minimum of 31 months of remaining shelf life upon receipt by the first government activity, as its total shelf life is 36 months and is non-extendable. Storage requirements mandate controlled room temperature between 15°C and 30°C (59°F–86°F), with protection from excessive heat and freezing. All packaging and labeling must strictly adhere to Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and must comply with DLA’s Master List of Technical and Quality Requirements. The ointment is regulated by the FDA and must be marked and shipped in accordance with commercial packaging standards, specifically ASTM D3951 if not classified as hazardous under FED-STD-313; however, DLA requirements take precedence over all other standards. Each shipment must be delivered FOB destination within five days, using the fastest traceable means, excluding parcel post, to the specified delivery point at Fort Lewis, WA. The product is identified by NSN 6505-01-189-7090, with a single purchase order quantity of one package, and the manufacturer is PADAGIS US LLC under NDC 00574-4024-39.
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325620
New
DIBBS
SUNSCREEN AND INSECT R
Solicitation # SPE2DP-26-T-4381
Toilet Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
RINGER'S INJECTION, LAC
Solicitation # SPE2DP-26-T-4395
RINGER'S INJECTION, LACTATED, USP, 1000ML, in packs of 12 units per case, is being procured under contract SPE2DP-26-T-4395 with a total order of 7 packing groups, equivalent to 84 individual units. The product is manufactured by B. Braun Medical Inc. with NDC 00264-7750-00 and is subject to FDA regulation. Packaging must comply strictly with Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and must ensure protection from damage and breakage during transit. Each unit must be sealed and packed in commercial shipping containers suitable for safe delivery via common carrier at the lowest cost to the specified destination, which is FPO AP 96675. The item has a non-extendable shelf life of 30 months and must be stored at room temperature (25°C), with brief exposure up to 40°C permitted. Packaging must adhere to DLA’s RP001 requirements and the latest DLA Master List of Technical and Quality Requirements, which take precedence over ASTM D3951. No hazard classification applies under FED-STD-313, so commercial packaging per ASTM D3951 is acceptable but subordinate to DLA standards. Delivery is required within 20 days of contract award, with zero quantity variance allowed, and inspection and acceptance occur at the delivery point. The unit of issue is packing group (PG), with each PG containing 12 units. All markings, labeling, and palletization must conform to specified DLA and federal standards, and shipping instructions must follow DLAD Proc Note C19 and C20. The solicitation closed on August 5, 2026, with an original required delivery date of August 3, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 424210
New
DIBBS
MICONAZOLE NITRATE POW
Solicitation # SPE2DP-26-T-4382
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE CLEANS
Solicitation # SPE2DP-26-T-4384
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
WATER FOR IRRIGATION, S
Solicitation # SPE2DP-26-T-4383
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
POVIDONE-IODINE TOP
Solicitation # SPE2DP-26-T-4386
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DEXTROSE INJECTION
Solicitation # SPE2DP-26-T-4393
Pharmaceutical Preparation Manufacturing

POSTED

about 16 hours ago

DEADLINE

in 5 days
View Details